Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-18

Clinical Trial Update: Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment [NA]

View source ↗

Summary

A clinical trial evaluating fampridine for improving working memory in individuals with post-COVID-19 condition and subjective cognitive impairment has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ampyra (4-aminopyridine)

Snippet

Sponsor: Prof. Dominique de Quervain, MD | Conditions: Working Memory, Post-covid-19 | NA | Status: TERMINATED